Sandra Mitchell, NCI/NIH
- Cognitive function and breast cancer: promise and potential insights from functional brain imaging
- Reducing the toxicity of cancer therapy: recognizing needs, taking action
- Cognitive dysfunction and cancer: which consequences in terms of disease management?
Eytan Domany, Weizmann Institute
- Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli
- Coupled two-way clustering analysis of gene microarray data
- Outcome signature genes in breast cancer: is there a unique set?
- Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
Jessie Au, The Ohio State University
- Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
- Computational Modeling to Predict Effect of Treatment Schedule on Drug Delivery to Prostate in Humans
- Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs
- Use of pharmacologic data and computer simulations to design an efficacy trial of intravesical mitomycin C therapy for superficial bladder cancer
Walter Stadler, University of Chicago
- Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment
- A phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status
- Diffusion weighted and dynamic contrast enhanced MR imaging of prostate cancer: Correlation of quantitative MR parameters with Gleason score and tumor angiogenesis
- Resampling phase III data to assess phase II trial designs and endpoints in renal cancer
No comments:
Post a Comment